03:15 AM EDT, 03/25/2026 (MT Newswires) -- Apogee Therapeutics ( APGE ) said late Tuesday it priced its underwritten public offering of 5 million shares at $70 apiece for gross proceeds of about $350 million.
The company has granted underwriters a 30-day period to purchase up to an additional 750,000 shares at the offering price.
The offering is expected to close on Thursday.